2024-09-03 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. (HCA) is a leading provider of healthcare services in the United States, operating hospitals and other healthcare facilities.

**Performance Analysis:**

**1. Performance Comparison:**

* **HCA's Cumulative Return:** 170.42%
* **S&P 500 (VOO) Cumulative Return:** 89.66%
* **Outperformance:** 80.76% (relative outperformance of 100%)

HCA has significantly outperformed the S&P 500 over the period analyzed, with a cumulative return that is 80.76% higher. This performance is at the upper end of its historical range, indicating strong performance relative to the broader market.

**2. Recent Price Movement:**

* **Closing Price:** 395.59
* **5-Day Moving Average:** 391.45
* **20-Day Moving Average:** 373.99
* **60-Day Moving Average:** 348.09

HCA's stock price has been trending upward in recent months, with the current price above all three moving averages. This suggests potential for continued momentum in the short term.

**3. Technical Indicators:**

* **RSI:** 99.19 (overbought)
* **PPO:** 0.22 (positive momentum)
* **Delta_Previous_Relative_Divergence:** 1.17 (short-term upward trend)
* **Expected_Return:** 0.0% (maximum 5-year expected return)

The high RSI value suggests that the stock is overbought and may be due for a correction. However, the positive PPO and Delta_Previous_Relative_Divergence indicate short-term upward momentum. The low expected return is likely due to the current high valuation and potential for correction.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

HCA has consistently delivered strong earnings growth, with EPS and revenue increasing in recent quarters. The company exceeded analyst expectations in its latest earnings report, signaling continued strong performance. Future prospects remain positive, driven by the aging population and rising healthcare demand.

**5. Overall Analysis:**

HCA's strong performance, driven by its consistent earnings growth and favorable industry outlook, has resulted in significant outperformance compared to the S&P 500. Despite the stock currently being overbought, technical indicators suggest short-term upward momentum. However, the high valuation and potential for correction should be considered. Investors should monitor the stock closely and consider the current market conditions before making any investment decisions.

**Disclaimer:** This analysis is for informational purposes only and does not constitute investment advice. 
